Company Valuation: Orexo AB

Data adjusted to current consolidation scope
Fiscal Period: December 2021 2022 2023 2024 2025 2026 2027 2028
Market Cap 1 1,184 648.2 532.1 603.8 1,039 440 - -
Change - -45.27% -17.9% 13.47% 72% -57.63% - -
Enterprise Value (EV) 1 1,173 791.1 809.5 940.6 609.4 335 440 437
Change - -32.54% 2.33% 16.19% -35.21% -45.03% 31.34% -0.68%
P/E -5.3x -3.65x -4.14x -2.97x 1.63x -1.2x -1.73x -1.62x
PBR 3.39x 3.34x 9.03x -4.78x 2.43x 2.86x - -90x
PEG - 0.2x 0.1x -0.1x -0x 0x 0.1x -0.24x
Capitalization / Revenue 2.1x 1.04x 0.83x 1.02x 1.98x 23.2x 16.3x 13.3x
EV / Revenue 2.08x 1.27x 1.27x 1.59x 1.16x 17.6x 16.3x 13.2x
EV / EBITDA -7.28x -6.87x -24.9x 19.2x 0.79x -1.16x -1.81x -1.67x
EV / EBIT -5.48x -4.3x -7.39x -22.8x 0.86x -1.04x -1.62x -1.51x
EV / FCF -4.16x -4.38x 7.65x -24.8x -3.12x -0.89x -1.98x -1.84x
FCF Yield -24% -22.8% 13.1% -4.03% -32.1% -112% -50.5% -54.5%
Dividend per Share 2 - - - - - - - -
Rate of return - - - - - - - -
EPS 2 -6.51 -5.17 -3.73 -5.89 18.46 -10.47 -7.28 -7.78
Distribution rate - - - - - - - -
Net sales 1 565 624.3 638.8 590 525.1 19 27 33
EBITDA 1 -161 -115.2 -32.5 48.9 772.3 -288 -243 -262
EBIT 1 -214.1 -183.9 -109.5 -41.2 705.3 -321 -272 -290
Net income 1 -223.5 -177.6 -128.3 -203 - -375 - -289.3
Net Debt 1 -11.7 142.9 277.4 336.8 -429.2 -105 - -3
Reference price 2 34.50 18.86 15.46 17.50 30.10 12.60 12.60 12.60
Nbr of stocks (in thousands) 34,328 34,368 34,421 34,505 34,505 34,922 - -
Announcement Date 1/27/22 1/26/23 2/8/24 2/6/25 2/5/26 - - -
1SEK in Million2SEK
Estimates

P/E, Detailed evolution



P/E (N) EV / Sales (N) EV / EBITDA (N) Dividend Yield (N) Capi.($)
108.76x6.06x25.7x2.28% 369B
22.45x3.05x10.64x1.77% 66.12B
15.46x7.55x11.57x - 12.65B
14.4x1.79x6.09x3.08% 7.5B
18.42x5.71x15.22x-.--% 4.42B
36.25x2.37x26.96x0.76% 4.1B
35.55x5.55x16.26x - 3.1B
-213.9x - - -.--% 2.49B
Average 4.67x 4.58x 16.06x 1.32% 58.65B
Weighted average by Cap. 88.90x 5.57x 22.72x 2.17%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA


-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!